How much do forgotten insulin injections matter to hemoglobin A1c in people with diabetes? A simulation study

Journal of Diabetes Science and Technology

Volumn 2, Issue 2, 2008, Pages 229-235

  Randløv, Jette ^a   Poulsen, Jens Ulrik ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Adherence; Compliance; HbA1c; Self treatment

Indexed keywords

EID: 80054678594     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200209     Document Type: Article

References (19)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.. N Engl J Med. 1993;329:977-86.
2. Burdick J, Chase H P, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.. Pediatrics. 2004 Mar; 113 (3Pt 1):e221-4..
3. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus.. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997;350(9090):1505-10.
4. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-24.
5. Anderson RT, Marrero D, Skovlund SE, Cramer J, Schwartz S. Selfreported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. 18th Congress of the International Diabetes Federation, Diabetologia. 2003;46(Suppl 2): A 275.
6. Cramer JA, Pugh MJ. The infuence of insulin use on glycemic control: How well do adults follow prescriptions for insulin? Diabetes Care.. 2005;28(1):78-83.
7. Rohlfng CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defning the relationship between plasma glucose and HbA (1c): analysis of glucose profles and HbA (1c) in the Diabetes Control and Complications Trial.. Diabetes Care. 2002;25(2):275-8.
8. Weinzimer S, Roy Beck R, Ruedy K, Booth A, Boland E; The Diabetes Research in Children Network (DirecNet) Study Group. Mealtime glycemic excursions in pediatric subjects with type 1 diabetes mellitus (T1DM): the DirecNetexperience Pediatr Res.. 2003;53(4Pt 2):1A-669A. http://public.direc. net/slides/mealtestposter4-30-03fnal.ppt.
9. Lehmann ED, Deutsch T. Compartmental models for glycaemic prediction and decision-support in clinical diabetes care: promise and reality.. Comput Methods Progr Biomed. 1998;56(2):193-204.
10. The AIDA simulator is available online: http://www.2aida.net/aida/index. shtml.
11. AIDA online [cited 2007 Oct. 31]. Available from: http://www.2aida. net.
12. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E. The glucose area under the profles obtained with continuous glucose monitoring system relationships with HbA (1c) in pediatric type 1 diabetic patients.. Diabetes Care. 2002;25(10):1840-4.
13. Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in type 1 diabetes? Diabet Med.. 2004;21(5):468-70.
14. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.. Clin Chem. 2007 May; 53(5):897-901.
15. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2007;30 (1) S4.
16. Goldstein DE, Peth SB, England JD, Hess RL, Da Costa J. Effects of acute changes in blood glucose on HbA1c. Diabetes. 1980;29(8):623-8.
17. Teague, J et al.: Infuence of blood glucose profle upon glycated haemoglobin in meal fed Zucker rats.. Diabet Med. 2005, 22 (Suppl 2):30.
18. Rajagopalan R, Joyce A, Ollendorf D, Murray FT. Medication compliance in type 2 diabetes subjects: retrospective data analysis. Value Health. 2003;6:328.
19. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.. Clin Ther. 2006;28(10):1712-25.